AEGiS-NYT: Guideline Given On Tracking Blood Data New York TimesImportant note: Information in this article was accurate in 1986. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu
DonateNow


Guideline Given On Tracking Blood Data

The New York Times - November 9, 1986
Sandra Friedland


HOSPITALS and community blood banks in New Jersey received detailed guidelines from Trenton last week on how to trace blood transfusions that may have involved AIDS-tainted blood.

Known as Operation Lookback, the effort will track units of blood and blood components from donors who gave blood before the AIDS screening test was instituted last spring and who now show evidence of exposure to the deadly virus.

The Lookback program will examine transfusion records back to Jan. 1, 1983. Since then, nearly two million units of blood and blood components have been transfused in New Jersey, but state officials estimated that only about 250 people would need to be notified that they might have received the now-suspect blood.

Those recipients will be urged to have their blood tested. If they received a transfusion that actually contained the AIDS virus, an unknown percentage now could be symptom-free AIDS carriers. They could be unwittingly spreading the virus to their sexual partners or unborn children.

In New Jersey, 3 percent of the adult AIDS victims, or 46 of the 1,530 cases, and 11 percent of the children with AIDS - 7 of the 60 cases - have been linked to transfusions.

In a statement introducing the guidelines, Dr. Ronald Altman, director of the state's AIDS program, stressed that, although the number of transfusion-related AIDS cases had been small, the fatal nature of the disease and questions about its transmission warranted an aggressive Lookback effort.

"It is entirely appropriate to do all in our power to insure the safety of the public," Dr. Altman said.

In a recent interview, he explained that the blood-collection agencies would start the Lookback process. Those agencies, which keep detailed records of the disposition of blood, will notify any hospitals that may have received suspect blood.

The hospitals then would try to trace recipients of any units of the blood that actually were transfused (some units may have been used for research or discarded).

Because most recipients of blood transfusions are critically ill, Dr. Altman said that a certain percentage of the patients who got the suspect blood probably had died during that hospital admission. Other patients may have died later.

Dr. Altman has asked hospitals to designate an infectious-disease specialist to coordinate efforts to contact any living recipients. The patient's attending doctor, if available, would also be consulted.

The hospital would offer an AIDS blood test to any patients and their sexual partners who can be found and, if the results were positive, counsel them on how to reduce the risk of spreading the infection.

If the recipient of the suspect blood died after the hospital admission, then the physician coordinating the Lookback effort would try to contact the patient's spouse or regular sexual partner and recommend a blood test.

The state's Department of Health will oversee this process and will, Dr. Altman said, act as the "tracer of last resort" if hospitals cannot find a patient or if the patient now lives outside the hospital's service area.

Ron Czajkowski, a spokesman for the Princeton-based New Jersey Hospital Association, said that the Lookback program was a product of cooperation between hospitals, physicians, the Department of Health and the blood banks.

He said that the hospital industry viewed AIDS as a public health problem and pushed to have the Health Department notify and counsel recipients of suspect blood.

However, Mr. Czajkowski said that the state's hospitals had accepted the role after state officials agreed to supply support with laboratory and counseling services.

Part of the Lookback program will involve data collections, Dr. Altman said.

"If we find a high percentage of recipients who test positive," he said, "then we may go back further than 1983. First, we want to see if this effort does any good."


861109
NYT861108


Copyright © 1986 - The New York Times Company. All Rights Reserved. All New York Times articles contained on the AEGiS web site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of The New York Times Company. You may not alter or remove any trademark, copyright or other notice from copies of the content. However, you may download articles (one machine readable copy and one print copy per page) for your personal, noncommercial use only.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, the Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 1986. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1986. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .